Madrid, Spain – 29 August: New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis, have been published today at ESC Congress 2025. This is the first time ...
A new expert consensus decision pathway from the American College of Cardiology (ACC) provides guidance around the management of myocarditis from diagnosis to follow-up. In light of recent advances in ...
Patients hospitalized for influenza are just as likely as those admitted for COVID-19 to have signs of myocardial involvement, according to a study out Ontario, Canada. Though patients with COVID-19 ...
Recommendations in the new ESC guidelines are largely consistent with those of the 2024 American College of Cardiology (ACC) expert consensus decision pathway on managing myocarditis, and a 2025 joint ...
Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis. Researchers led by physicians and ...
Researchers document the harmful consequences of myocarditis in preschool students, caused by a regional outbreak of parvovirus B19 in northern Greece. Myocarditis is a rare yet serious condition ...
Heart inflammation, or myocarditis, differs depending on its cause. A collaborative study led by Dr. Henrike Maatz, a ...
New research has found that patients who developed inflammation of the heart, or myocarditis, after receiving an mRNA vaccine for COVID-19 had fewer complications in the 18 months after ...
No elevation of markers of myocardal lesion (i.e., troponin) No evidence of new wall motion abnormalities or ventricular dysfunction † † In case of new evidence of wall motion abnormalities or ...
Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents—and they've shown a possible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results